Selected Grants
A Phase III, Multicenter, Randomized, Double¿Masked, Sham¿Controlled Study to Investigate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of RO7200220 Administered Intravitreally in Patients with Uveitic Macular Edema
Clinical TrialPrincipal Investigator · Awarded by Genentech, Inc. · 2023 - 2028External Relationships
- Carl Zeiss Meditec
- Genentech
- Kala Pharmaceuticals
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.